University of California, Los Angeles: Hypertension trials
The registry lists 13 Hypertension studies with University of California, Los Angeles as lead sponsor. 0 are open to participants now and 2 have results posted.
Phase 4 2No phase 11(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Iloprost for the Treatment of Pulmonary Hypertension in Adults With Congenital Heart DiseaseTerminatedNCT01319045Not applicableResults posted
- Exercise Induced Pulmonary Hypertension in Systemic Sclerosis and Treatment With AmbrisentanCompletedNCT01051960Phase 4Results posted
- Multi-ethnic Multi-level Strategies and Behavioral Economics to Eliminate Hypertension Disparities in Los Angeles CountyActive, not recruitingNCT06359691Not applicable
- PIMR and Pulmonary Vascular DiseaseCompletedNCT05843461
- Cardiovascular Risk Reduction in EpilepsyWithdrawnNCT05704439Not applicable
- University of California Health Remote (Home) Monitoring EvaluationActive, not recruitingNCT05390502Not applicable
- Promoting Adherence to Anti-Hypertensive Medications and Lifestyle Guidelines Through Mindfulness PracticeCompletedNCT03924531Not applicable
- MyLife: A Digital Health Coaching ProgramCompletedNCT03529903Not applicable
- Culturally Tailoring a Stroke Intervention in Community Senior CentersCompletedNCT02181062Not applicable
- Efficacy of Remodulin in Adults With Congenital Heart Disease (ACHD) and Pulmonary HypertensionWithdrawnNCT01980979Not applicable
- Monetary Incentives and Intrinsic Motivation to Sustain Hypertension ControlCompletedNCT01402453Not applicable
- Pulmonary Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With SildenafilWithdrawnNCT00625079Phase 4
- Health and Faith Working to Control Blood PressureCompletedNCT00535444Not applicable